TearLab Corp. (TEAR) Starts Presentation at LD Micro Invitational Conference

TearLab (NASDAQ: TEAR) develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care.  The TearLab Osmolarity^® Test, for diagnosing Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System. For more information, visit the company’s website at www.tearlab.com